Uscom attended the European Congress of the International Society for the Study of Hypertension in Pregnancy (ISSHP) this month, which took place in Berlin.
The event was a huge success with four days of world-class research and exciting science highlighting incredible commitment to improving pregnancy outcomes in women with hypertensive disorders of pregnancy.
There was a lot of interest in the USCOM 1A, given its important use in the non-invasive early detection of maladaptation to the normal hemodynamic changes of pregnancy.
High systemic vascular resistance (SVR) is found in high risk patients with intrauterine growth restriction (IUGR), gestational hypertension (GH) and early preeclampsia (PE) one of the leading causes of maternal and fetal morbidity and mortality. Early preeclampsia with IUGR is associated with a high SVRI & low cardiac output (CO) and late preeclampsia is associated with high SVRI & high CO, resulting in large growth for age babies.
Overall, the USCOM1A was generating a lot of interest in the field of maternal-fetal management, and we are proud to be at the forefront of the growing international community of researchers and clinics committed to improving both maternal and fetal outcomes in cardiovascular related disorders of pregnancy.